Problems of cell death in neurodegeneration and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 3, Issue 1, 2001, Pages 31-40

  Jellinger, Kurt A ^a   Stadelmann, Christine ^b  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Activated caspase 3; Alzheimer's disease; Apoptose related proteins; Parkinson's disease; Programmed cell death

Indexed keywords

CASPASE 3; DNA FRAGMENT; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MICROGLIA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NICK END LABELING; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE;

EID: 0035077448     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3106     Document Type: Article

References (104)

1. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease
2. Neuropathology of synuclein aggregates. New insights into mechanism of neurodegenerative diseases
3. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB International Workshop
4. The definition of multiple system atrophy: A review of recent developments
5. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
6. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
7. Cell death: The significance of apoptosis
8. Apoptosis, oncosis, and necrosis. An overview of cell death
9. Cellular signaling pathways in neuronal apoptosis. Role in neurodegeneration and Alzheimer's disease
10. Mechanism of apoptosis
11. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
12. Neuronal apoptosis induced by β-amyloid is mediated by caspase 8
13. Caspase cleavage of APP results in a cytotoxic proteolytic peptid
14. A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor
15. Neurodegeneration induced by aggregated Aβ in central nerons may be apoptotic
16. Selective increase in cellular A beta 42 is related to apoptosis but not necrosis
17. DNA damage and apoptosis in the aged canine brain: Relationship to Aβ deposition in the absence of neuritic pathology
18. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease
19. Apoptosis in neurodegenerative diseases: The role of mitochondria
20. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area and effect of post mortem delay
21. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
22. Bax protein expression is increased in Alzheimers brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology
23. Bcl-2 and Bax protein expression in Alzheimer's disease
24. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease
25. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease
26. Upregulation of the anti-apoptotic protein Bcl-2 may be early event in neurodegeneration: Studies on Parkinson's incidental Lewy body disease
27. Participation of Par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid
28. Programmed cell death: Does it play a role in Parkinson's disease?
29. Expression of Bcl 2 in adult human brain regions with special reference to neurodegenerative disorders
30. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
31. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
32. DNA damage distribution in the human brain as shown by in situ end labelling. Area-specific differences in aging and Alzheimer's disease in the absence of apoptotic morphology
33. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability but not apoptosis
34. DNA strand breaks in Alzheimer's disease
35. Differential distribution of presenilin-1, Bax, and Bcl-X in Alzheimer's disease and frontotemporal dementia
36. Cell mechanisms in multiple system atrophy
37. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
38. DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
39. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum
40. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease
41. DNA damage and activated caspase-3 expression in neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia
42. Increased caspase-3 and BAX immunoreactivity accompanying nuclear GAPDH translocations and neuronal apoptosis in Parkinson's disease
43. Neuropathological stageing of Alzheimer-related changes
44. Tissue pH as an indicator of mRNA preservation in post-mortem brain
45. In situ immunodetection of activated caspase 3 in apoptotic neurons in the developing nervous system
46. Activation of caspase 3 in single apopototic neurons and granules of granulovacuolar degeneration in Alzheimer disease and Down's syndrome: A role for autophagy as antiapoptotic counterregulatory mechanism?
47. Cell death mechanisms in Parkinson's disease
48. Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques
49. Detection of apoptosis in tissue sections
50. Morphological and biochemical assessment of DNA darrage and apoptosis in Down syndrome and Alzheimer disease and effects of postmortem tissue archival on TUNEL
51. Caspase-3 is activated in Alzheimer disease but not in frontotemporal dementia
52. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease
53. Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease
54. Apoptosis in neurodegenerative disorders
55. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
56. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
57. Etiology and pathogenesis of Parkinson's disease
58. The cause of neuronal degeneration in Alzheimer's disease
59. In situ immunodetection of neuronal caspase 3 activation in Alzheimer disease
60. On the question of apoptosis in the parkinsonian substantia nigra
61. Glial pathology but absence of apoptotic nigral neurons in long standing Parkinson's disease
62. DNA fragmentation in neurons and glial cells indicates cellular injury but not apoptosis in Pick's disease
63. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
64. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits
65. Apopototic activities of wild-type and Alzheime's disease related mutant presenilins in Drosophila melanogaster
66. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production
67. Increased vunerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation
68. Mechanisms of cell death in Alzheimer's disease: Role of presenilin and mitochondrial functions
69. Generation of antiapoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase 3 cleavage
70. G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP
71. Inhibition of NF-κ B potentiates amyloid β-mediated neuronal apoptosis
72. Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis
73. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer's disease
74. DNA-fragmentation, gliosis and histological hallmarks of Alzheimer's disease
75. DNA damage does not correlate with amyloid-β-plaques and neurofibrillary tangles in familial Alzheimer's disease presenilin-1 (E280A) mutation
76. Ultrastructural evidence of cell death by necrosis in familial Alzheimer's disease (FAD) PS1-E280A brains
77. Presenilins and cellular damage: A link through amyloid?
78. Abnormal expression of the cell cycle regulators P 16 and CDK4 in Alzheimer's disease
79. Apoptosis and Alzheimer's disease
80. A suicide note from Alzheimer disease neurons?
81. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brains
82. Caspase 3. A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
83. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
84. Apoptosis in neuronal development and transplantation (1998) role of caspases and trophic factors
85. Calpain and caspase; can you tell the difference?
86. Multiple system atrophy: A sporadic synucleinopathy
87. Induction of neuronal death by α-synuclein
88. Myelin degeneration in multiple system atrophy detected by unique antibodies
89. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models
90. Contribution of somal Lewy bodies to neuronal death
91. Neurons may live for decades with neurofibrillary tangles
92. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A
93. Solubility of α-synuclein differs between multiple system atrophy and dementia with Lewy bodies
94. Oxidative stress in Alzheimer disease
95. Mechanisms of neurodegenerative disorders. Part I. Protein aggregates
96. Mechanisms of neurodegenerative disorders. Part II. Control of cell death
97. GADD45 is induced in Alzheimer's disease, and protects against apoptosis in vitro
98. Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus
99. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease
100. Apoptosis versus necrosis
101. Neuronal cell death
102. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
103. Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases
104. Apoptosis in the nervous system